Our research discovered that all members of the KMT2 family were linked with subtypes of immune invasion in the tumor microenvironment, with KMT2B and KMT2F being associated with more aggressive subtypes of immune invasion, notably C1, C2, and C6, and poor prognosis. This evidence concerns the gene KMT2B and neoplasm.